Bio-Gene Technology Ltd. ( ($AU:BGT) ) has issued an announcement. Bio-Gene Technology Ltd. has released its Corporate Governance Statement, ...

The latest announcement is out from Bio-Gene Technology Ltd. ( ($AU:BGT) ). Bio-Gene Technology Limited released its 2025 Annual Report, ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

There's a fresh push to edit the genes of human embryos to prevent diseases and enhance characteristics that parents value.

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

Within the next 25 years, China may become the first country in the world to build a nationwide genomic database covering its ...

A gene called ASDL, which helps synthesize DNA, differs between modern humans and our extinct human relatives. The findings ...

In Australia, gene technology, including genetically modified and gene-edited crops, is regulated by the Office of the Gene Technology Regulator (OGTR).

On World Mosquito Day, Target Malaria, a not-for-profit research consortium, has called for more investment in technology, ...

Bio-Gene Technology Ltd. has announced its 2024 Annual General Meeting to be held on November 29 as a hybrid event, allowing shareholders to participate either in-person in Melbourne or online.

A gene called SDR42E1 has been identified as a key player in how our bodies absorb and process vitamin D. Researchers found that disabling this gene in colorectal cancer cells not only crippled ...